Rencontrez-nous à…
Toute l’actualité d’OTR3
Lungs/Poumons | Media Publications
Manon Barthe (1) , Laurie Perdigon (1) , Hanan Osman-Ponchet (1) , Agnès Choppin (2) , Franck Chiapini (2) Pulmonary fibrosis is a progressive, restrictive lung disease characterized by scarring and stiffening of lung tissue, ultimately leading to respiratory failure. This condition is driven by the excessive proliferation and migration [...]
Lungs/Poumons | Media Publications
Laurie Perdigon (1) , Manon Barthe (1) , Jean-Paul Thénot (1) , Franck Chiappini (2) , Agnes Choppin (2) , Hanan Osman-Ponchet (1) Occurrence of diffuse alveolar damage is a real storm in the course of pulmonary diseases leading to an acute and/or chronic inflammatory processes with poorly understood etiologies [...]
CLERAPLIQ
Clerapliq -Prise en charge médicale des ulcères cornéens avec RGTA Cas clinique - L'Essentiel Bertrand Michaud - Docteur vétérinaire Les ulcères cornéens sont des affections fréquemment rencontrées en pratique vétérinaire quotidienne. Leur trai- tement passe par la mise en évidence de l’origine de la lésion. Ainsi, le traitement devra [...]
News
OTR3 announces first patient enrolled in a Phase I study of OTR4132-MD in Acute Ischemic Stroke (AIS).
News
OTR3 announces first patient enrolled in a post market clinical follow up on Cacipliq 20®..
News
OTR3 receives approval from ANSM to start new clinical trial with the application of a RGTA® product in ischemic stroke.
